DLG4 and nervous system disorder: Its aberrant expression has been observed in numerous neurological disorders (Arbuckle et al., 2010; Bustos et al., 2017; De Bartolomeis et al., 2014; Savioz, Leuba & Vallet, 2014; Zhang et al., 2014), with previous research suggesting that enhancing PSD95 expression may bolster synapse count and minimize neuronal death (Wang et al., 2020b).